Nov 7, 2015 by Brian Orelli, PhDGenomic Health, Inc. on Path to ProfitabilityStrong growth in tests combined with an increase in reimbursement.
Nov 6, 2015 by Brian Orelli, PhDWhy Celldex Therapeutics, Inc. Bounded Higher TodayInvestors are excited about the biotech's future.
Nov 6, 2015 by Brian Orelli, PhDWhy Orexigen Therapeutics, Inc.'s Stock Is Losing Weight TodayDiscounts and a lack of a European partner derail the obesity drugmaker.
Nov 5, 2015 by Brian Orelli, PhDWhy Valeant Pharmaceuticals Intl Inc. Fell Again TodayNew day, same old issues for the drugmaker.
Nov 5, 2015 by Brian Orelli, PhDCelgene Corporation Mixed Bag of EarningsThe big biotech's drugs produce mixed sales results.
Nov 5, 2015 by Brian Orelli, PhDHere's Why bluebird bio Inc Crash Landed TodayThe American Society of Hematology (ASH) abstracts weren't what investors were hoping for.
Nov 4, 2015 by Brian Orelli, PhDHere's Why Genomic Health, Inc. Popped TodayTest growth trajectory puts the company on track towards profitability.
Nov 3, 2015 by Brian Orelli, PhDSeattle Genetics, Inc. Earnings: Extending the RunwayThe biotech has plenty of cash to get it to profitability.
Nov 3, 2015 by Brian Orelli, PhDWhat to Expect From Celgene Corporation's Earnings ReportEarnings will be released Thursday morning.
Nov 2, 2015 by Brian Orelli, PhDNovo Nordisk A/S Earnings: Benefiting From a Stronger DollarThe joys of reporting in the Danish kroner.
Nov 2, 2015 by Brian Orelli, PhDHere's Why MedAssets, Inc. Jumped 30% TodayThe healthcare performance improvement company is getting acquired.
Nov 1, 2015 by Brian Orelli, PhDBioMarin Pharmaceutical Inc. Earnings: Pushing Toward ProfitabilityWith sales of its existing drugs growing well, the biotech turns its eye to the approval of its Duchenne muscular dystrophy drug Kyndrisa (drisapersen), which should lead to profitability.
Nov 1, 2015 by Brian Orelli, PhDQiagen NV Earnings: Just What You'd ExpectNothing special here, but nothing bad, either. Look forward to 2016.
Nov 1, 2015 by Brian Orelli, PhDVertex Pharmaceuticals Incorporated: Profit on the HorizonThe launch of Orkambi is going exceptionally well.
Oct 31, 2015 by Brian Orelli, PhDIdexx Laboratories, Inc.: Solid Earnings. Guidance, Not So Much.The animal diagnostic testing company is having one-time issues with taxes, currency changes, and macroeconomic issues
Oct 31, 2015 by Brian Orelli, PhDBaxalta-Free Earnings at Baxter International IncThe medical supplies company reports its first quarter without its biotech division.
Oct 31, 2015 by Brian Orelli, PhDImmunoGen, Inc. Pushes Its Pipeline ForwardThe biotech's earnings call was all about the pipeline.
Oct 30, 2015 by Brian Orelli, PhDWhy Valeant Pharmaceuticals Intl Inc Tumbled Again TodayMore issues with its associated specialty pharmacy, Philidor.
Oct 30, 2015 by Brian Orelli, PhDHere's Why Arena Pharmaceuticals, Inc. Is Struggling TodaySales of Belviq are still floundering.
